BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Business > article

Standigm partners with CJ HealhCare to develop anti-cancer drug candidates

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : December 17, 2019, 14:13 | Updated : December 17, 2019, 14:13
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Standigm]

SEOUL -- Standigm, a promising startup known for cutting-edge AI technologies applied to drug discovery, agreed with CJ HealthCare to jointly research and develop innovative anti-cancer drug candidates. The startup focuses on predicting new indications for existing drugs.

Under their partnership signed on Tuesday, Standigm will use AI platforms to find new compound structures, while CJ Healthcare, a drugmaker and bio company, will find new drug candidates through material composition and evaluation by 2021.

Standigm removes the traditional guesswork from data analysis by using AI, automatically examining whole biomedical databases to learn what is hiding just out of sight. Standigm is well known for its AI platforms such as Standigm BEST, a material optimization platform, and Standigm InsightTM, an indication and mechanism of action prediction platform.

Founded in 2015 by AI and systems biology experts, Standigm's growth potential has been acknowledged among pharmaceutical companies and secured a series of investments from investors, including 10 billion won ($8.5 million) from SK Holdings in November. Standigm has generated tens of drug candidates for cancers, Parkinson’s disease, autism, fatty liver diseases.

CJ HealthCare has stepped up the development of new drugs since it was acquired by Korea Kolmar, a beauty and pharmaceutical company, in February 2018, for 1.31 trillion won.




 

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Boryung secure exclusive rights to sell nano-particle anticancer drug developed by SN Bioscience.
    Boryung secure exclusive rights to sell nano-particle antica…
  • .Medytox acquires 16.7% stake in Daewoongs U.S. partner for ending legal battle.
    Medytox acquires 16.7% stake in Daewoong's U.S. partner for …
  • .U.S. research company Lifex works with S. Koreas Macrogen to develop Parkinsons disease treatment.
    U.S. research company Lifex works with S. Korea's Macrogen t…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view